Trial Profile
A randomized, open-label study evaluating pharmacokinetics of AXS-05 in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Jan 2016
Price :
$35
*
At a glance
- Drugs Bupropion/dextromethorphan (Primary)
- Indications Agitation; Depressive disorders
- Focus Pharmacokinetics
- 13 Jan 2016 New trial record
- 19 Nov 2015 Results were published in the SEC Form 424B2 for Axsome Therapeutics.